Evidence map›Paper›PMID 29142105›Full record

ArticleOpen biology2017

The

Nicholas J Bradshaw, Liisa Ukkola-Vuoti, Maiju Pankakoski, Amanda B Zheutlin, Alfredo Ortega-Alonso, Minna Torniainen-Holm, Vishal Sinha, Sebastian Therman, Tiina Paunio, Jaana Suvisaari and 4 more

Open access · goldAbstract read
In one paragraph

Article in Open biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. International journal of molecular sciences · 2023
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Role ofFrontiers in neuroscience · 2020
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 4 countries.

Nicholas J BradshawDepartment of Neuropathology, Heinrich Heine University, 40225 Düsseldorf, Germany.ORCID 0000-0001-5581-8828
Liisa Ukkola-VuotiMental Health Unit, Department of Health, National Institute for Health and Welfare, 00271 Helsinki, Finland.
Maiju PankakoskiMental Health Unit, Department of Health, National Institute for Health and Welfare, 00271 Helsinki, Finland.
Amanda B ZheutlinDepartment of Psychology, Yale University, New Haven, CT 06520, USA.
Alfredo Ortega-AlonsoMental Health Unit, Department of Health, National Institute for Health and Welfare, 00271 Helsinki, Finland.
Minna Torniainen-HolmMental Health Unit, Department of Health, National Institute for Health and Welfare, 00271 Helsinki, Finland.
Vishal SinhaMental Health Unit, Department of Health, National Institute for Health and Welfare, 00271 Helsinki, Finland.
Sebastian ThermanMental Health Unit, Department of Health, National Institute for Health and Welfare, 00271 Helsinki, Finland.
Tiina PaunioGenomics and Biomarkers Unit, Department of Health, National Institute for Health and Welfare, 00271 Helsinki, Finland.
Jaana SuvisaariMental Health Unit, Department of Health, National Institute for Health and Welfare, 00271 Helsinki, Finland.
Jouko LönnqvistMental Health Unit, Department of Health, National Institute for Health and Welfare, 00271 Helsinki, Finland.
Tyrone D CannonDepartment of Psychology, Yale University, New Haven, CT 06520, USA.
Jari HaukkaMental Health Unit, Department of Health, National Institute for Health and Welfare, 00271 Helsinki, Finland.
William HennahMental Health Unit, Department of Health, National Institute for Health and Welfare, 00271 Helsinki, Finland william.hennah@helsinki.fi.ORCID 0000-0002-4462-4208
University of Helsinki · FIFinnish Institute for Health and Welfare · FIYale University · USUniversity of Rijeka · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetic studies of familial schizophrenia in Finland have observed significant associations with a group of biologically related genes,

Indexed as

Polymorphism, Single NucleotideAntipsychotic AgentsCell Line, TumorCytochrome P-450 CYP2C19FemaleHumansMaleMicroRNAsMicrotubule-Associated ProteinsNerve Tissue ProteinsPharmacogeneticsSchizophreniaAntipsychotic AgentsCYP2C19 protein, humanCytochrome P-450 CYP2C19DISC1 protein, humanMicroRNAsMicrotubule-Associated ProteinsMIRN484 microRNA, humanNde1 protein, humanNerve Tissue ProteinsDISC1 networkgene expressionmiR-484NDE1pharmacogeneticsschizophrenia

Identifiers

PMID29142105
PMCPMC5717342
OpenAlexW2771469211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.